APA

Muenst S., Schaerli A. R., Gao F., Däster S., Trella E., Droeser R. A., Muraro M. G., Zajac P., Zanetti R., Gillanders W. E., Weber W. P. & Soysal S. D. (20150818). Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. : Breast cancer research and treatment.

Chicago

Muenst S, Schaerli A R, Gao F, Däster S, Trella E, Droeser R A, Muraro M G, Zajac P, Zanetti R, Gillanders W E, Weber W P and Soysal S D. 20150818. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. : Breast cancer research and treatment.

Harvard

Muenst S., Schaerli A. R., Gao F., Däster S., Trella E., Droeser R. A., Muraro M. G., Zajac P., Zanetti R., Gillanders W. E., Weber W. P. and Soysal S. D. (20150818). Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. : Breast cancer research and treatment.

MLA

Muenst S, Schaerli A R, Gao F, Däster S, Trella E, Droeser R A, Muraro M G, Zajac P, Zanetti R, Gillanders W E, Weber W P and Soysal S D. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. : Breast cancer research and treatment. 20150818.